China Pharmaceutical Trade: Other Biochemicals and Western Medicines

Export: Agar

2010 - 2022 | Monthly | USD th | General Administration of Customs

CN: Export: Agar data was reported at 10,025.921 USD th in May 2022. This records an increase from the previous number of 8,275.219 USD th for Apr 2022. CN: Export: Agar data is updated monthly, averaging 6,018.505 USD th from Jan 2010 to May 2022, with 149 observations. The data reached an all-time high of 11,636.171 USD th in Jan 2015 and a record low of 2,552.000 USD th in Feb 2010. CN: Export: Agar data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
10,025.921 May 2022 monthly Jan 2010 - May 2022

View China's Export: Agar from Jan 2010 to May 2022 in the chart:

China Export: Agar

China Export: Bacteria & Virus under Sensitive Item Control

2012 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Bacteria & Virus under Sensitive Item Control data was reported at 0.000 USD th in Jan 2018. This stayed constant from the previous number of 0.000 USD th for Jan 2017. CN: Export: Bacteria & Virus under Sensitive Item Control data is updated monthly, averaging 0.000 USD th from Feb 2012 to Jan 2018, with 9 observations. The data reached an all-time high of 0.005 USD th in Oct 2015 and a record low of 0.000 USD th in Jan 2018. CN: Export: Bacteria & Virus under Sensitive Item Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Jan 2018 monthly Feb 2012 - Jan 2018

View China's China Export: Bacteria & Virus under Sensitive Item Control from Feb 2012 to Jan 2018 in the chart:

China China Export: Bacteria & Virus under Sensitive Item Control

China Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale)

2014 - 2016 | Monthly | USD th | General Administration of Customs

CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data was reported at 0.000 USD th in Dec 2016. This stayed constant from the previous number of 0.000 USD th for Sep 2016. CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data is updated monthly, averaging 0.000 USD th from Mar 2014 to Dec 2016, with 9 observations. The data reached an all-time high of 0.000 USD th in Dec 2016 and a record low of 0.000 USD th in Dec 2016. CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Dec 2016 monthly Mar 2014 - Dec 2016

View China's China Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale) from Mar 2014 to Dec 2016 in the chart:

China China Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale)

China Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)

2014 - 2016 | Monthly | USD th | General Administration of Customs

CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data was reported at 1,375.028 USD th in Dec 2016. This records a decrease from the previous number of 2,155.338 USD th for Nov 2016. CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data is updated monthly, averaging 1,146.273 USD th from Jan 2014 to Dec 2016, with 36 observations. The data reached an all-time high of 2,370.202 USD th in Mar 2014 and a record low of 547.281 USD th in May 2014. CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
1,375.028 Dec 2016 monthly Jan 2014 - Dec 2016

View China's China Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) from Jan 2014 to Dec 2016 in the chart:

China China Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)

China Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data was reported at 0.050 USD th in Feb 2018. This records a decrease from the previous number of 0.093 USD th for Dec 2017. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data is updated monthly, averaging 0.093 USD th from Jan 2011 to Feb 2018, with 65 observations. The data reached an all-time high of 21.045 USD th in Sep 2011 and a record low of 0.000 USD th in Mar 2016. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.050 Feb 2018 monthly Jan 2011 - Feb 2018

View China's China Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal from Jan 2011 to Feb 2018 in the chart:

China China Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal

China Export: Extract of Gland or Other Organ or of their Secretion, of Human

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human data was reported at 399.482 USD th in Mar 2018. This records a decrease from the previous number of 1,038.644 USD th for Feb 2018. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human data is updated monthly, averaging 575.878 USD th from Jan 2011 to Mar 2018, with 87 observations. The data reached an all-time high of 2,220.784 USD th in Jan 2017 and a record low of 0.000 USD th in Apr 2016. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
399.482 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Export: Extract of Gland or Other Organ or of their Secretion, of Human from Jan 2011 to Mar 2018 in the chart:

China China Export: Extract of Gland or Other Organ or of their Secretion, of Human

China Export: Extract of Gland or Other Organ or of their Secretion, of Others

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others data was reported at 810.813 USD th in Mar 2018. This records an increase from the previous number of 696.714 USD th for Feb 2018. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others data is updated monthly, averaging 568.576 USD th from Jan 2011 to Mar 2018, with 87 observations. The data reached an all-time high of 1,700.469 USD th in Mar 2013 and a record low of 0.256 USD th in Feb 2014. CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
810.813 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Export: Extract of Gland or Other Organ or of their Secretion, of Others from Jan 2011 to Mar 2018 in the chart:

China China Export: Extract of Gland or Other Organ or of their Secretion, of Others

China Export: Insulin-Like Growth Factors-1

2014 - 2016 | Monthly | USD th | General Administration of Customs

CN: Export: Insulin-Like Growth Factors-1 data was reported at 0.000 USD th in May 2016. This stayed constant from the previous number of 0.000 USD th for Dec 2015. CN: Export: Insulin-Like Growth Factors-1 data is updated monthly, averaging 0.000 USD th from Mar 2014 to May 2016, with 12 observations. The data reached an all-time high of 0.000 USD th in May 2016 and a record low of 0.000 USD th in May 2016. CN: Export: Insulin-Like Growth Factors-1 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 May 2016 monthly Mar 2014 - May 2016

View China's China Export: Insulin-Like Growth Factors-1 from Mar 2014 to May 2016 in the chart:

China China Export: Insulin-Like Growth Factors-1

Export: Medicament Containing Artemisinin & their Derivative

2009 - 2022 | Monthly | USD th | General Administration of Customs

CN: Export: Medicament Containing Artemisinin & their Derivative data was reported at 7,298.555 USD th in May 2022. This records a decrease from the previous number of 9,206.350 USD th for Dec 2020. CN: Export: Medicament Containing Artemisinin & their Derivative data is updated monthly, averaging 5,623.151 USD th from Jan 2009 to May 2022, with 97 observations. The data reached an all-time high of 15,873.820 USD th in Nov 2020 and a record low of 0.000 USD th in Jan 2009. CN: Export: Medicament Containing Artemisinin & their Derivative data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
7,298.555 May 2022 monthly Jan 2009 - May 2022

View China's Export: Medicament Containing Artemisinin & their Derivative from Jan 2009 to May 2022 in the chart:

China Export: Medicament Containing Artemisinin & their Derivative

China Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose

2009 - 2020 | Monthly | USD th | General Administration of Customs

CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose data was reported at 12.500 USD th in Dec 2020. This records a decrease from the previous number of 104.681 USD th for Nov 2020. CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose data is updated monthly, averaging 46.815 USD th from Jan 2009 to Dec 2020, with 72 observations. The data reached an all-time high of 1,895.436 USD th in Jul 2011 and a record low of 0.000 USD th in Aug 2016. CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
12.500 Dec 2020 monthly Jan 2009 - Dec 2020

View China's China Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose from Jan 2009 to Dec 2020 in the chart:

China China Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose

China Export: Medicament Containing Quinine & its Salt, Not in Measured Dose

2012 - 2016 | Monthly | USD th | General Administration of Customs

CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose data was reported at 30.448 USD th in Dec 2016. This records an increase from the previous number of 0.000 USD th for Nov 2016. CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose data is updated monthly, averaging 1.833 USD th from Jan 2012 to Dec 2016, with 20 observations. The data reached an all-time high of 38.841 USD th in Apr 2012 and a record low of 0.000 USD th in Nov 2016. CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
30.448 Dec 2016 monthly Jan 2012 - Dec 2016

View China's China Export: Medicament Containing Quinine & its Salt, Not in Measured Dose from Jan 2012 to Dec 2016 in the chart:

China China Export: Medicament Containing Quinine & its Salt, Not in Measured Dose

China Export: Medicament Containing Taxinol

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Medicament Containing Taxinol data was reported at 0.000 USD th in Mar 2018. This records a decrease from the previous number of 1,285.462 USD th for Feb 2018. CN: Export: Medicament Containing Taxinol data is updated monthly, averaging 38.152 USD th from Jan 2011 to Mar 2018, with 86 observations. The data reached an all-time high of 6,436.913 USD th in Sep 2015 and a record low of 0.000 USD th in Mar 2018. CN: Export: Medicament Containing Taxinol data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Export: Medicament Containing Taxinol from Jan 2011 to Mar 2018 in the chart:

China China Export: Medicament Containing Taxinol

China Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose

2011 - 2016 | Monthly | USD th | General Administration of Customs

CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data was reported at 29,095.438 USD th in Dec 2016. This records an increase from the previous number of 24,433.772 USD th for Nov 2016. CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data is updated monthly, averaging 19,425.300 USD th from Jan 2011 to Dec 2016, with 72 observations. The data reached an all-time high of 29,095.438 USD th in Dec 2016 and a record low of 9,910.714 USD th in Oct 2011. CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
29,095.438 Dec 2016 monthly Jan 2011 - Dec 2016

View China's China Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose from Jan 2011 to Dec 2016 in the chart:

China China Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose

Export: Other Antisera, Other Blood Fractions & Modified Immunological Product

2012 - 2016 | Monthly | USD th | General Administration of Customs

CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product data was reported at 196,535.668 USD th in Dec 2016. This records an increase from the previous number of 36,602.086 USD th for Nov 2016. CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product data is updated monthly, averaging 24,969.798 USD th from Jan 2012 to Dec 2016, with 60 observations. The data reached an all-time high of 196,535.668 USD th in Dec 2016 and a record low of 11,953.726 USD th in Mar 2012. CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
196,535.668 Dec 2016 monthly Jan 2012 - Dec 2016

View China's Export: Other Antisera, Other Blood Fractions & Modified Immunological Product from Jan 2012 to Dec 2016 in the chart:

China Export: Other Antisera, Other Blood Fractions & Modified Immunological Product

China Export: Other Bacteria & Virus

2009 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Other Bacteria & Virus data was reported at 769.824 USD th in Mar 2018. This records an increase from the previous number of 515.054 USD th for Feb 2018. CN: Export: Other Bacteria & Virus data is updated monthly, averaging 70.650 USD th from Jan 2009 to Mar 2018, with 109 observations. The data reached an all-time high of 1,593.488 USD th in Jan 2018 and a record low of 0.000 USD th in Feb 2011. CN: Export: Other Bacteria & Virus data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
769.824 Mar 2018 monthly Jan 2009 - Mar 2018

View China's China Export: Other Bacteria & Virus from Jan 2009 to Mar 2018 in the chart:

China China Export: Other Bacteria & Virus

Export: Other Insulin & its Salt

2011 - 2022 | Monthly | USD th | General Administration of Customs

CN: Export: Other Insulin & its Salt data was reported at 659.029 USD th in May 2022. This records a decrease from the previous number of 1,318.711 USD th for Feb 2022. CN: Export: Other Insulin & its Salt data is updated monthly, averaging 1.000 USD th from Mar 2011 to May 2022, with 83 observations. The data reached an all-time high of 4,168.548 USD th in Dec 2011 and a record low of 0.000 USD th in Mar 2018. CN: Export: Other Insulin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
659.029 May 2022 monthly Mar 2011 - May 2022

View China's Export: Other Insulin & its Salt from Mar 2011 to May 2022 in the chart:

China Export: Other Insulin & its Salt

China Export: Other Medicament, in Measured Dose

2011 - 2014 | Monthly | USD th | General Administration of Customs

CN: Export: Other Medicament, in Measured Dose data was reported at 133,171.900 USD th in Dec 2014. This records a decrease from the previous number of 161,009.937 USD th for Nov 2014. CN: Export: Other Medicament, in Measured Dose data is updated monthly, averaging 128,216.740 USD th from Jan 2011 to Dec 2014, with 48 observations. The data reached an all-time high of 161,329.209 USD th in Mar 2014 and a record low of 44,564.586 USD th in Feb 2011. CN: Export: Other Medicament, in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
133,171.900 Dec 2014 monthly Jan 2011 - Dec 2014

View China's China Export: Other Medicament, in Measured Dose from Jan 2011 to Dec 2014 in the chart:

China China Export: Other Medicament, in Measured Dose

Export: Other Protein Substance & their Derivative

2009 - 2022 | Monthly | USD th | General Administration of Customs

CN: Export: Other Protein Substance & their Derivative data was reported at 80,656.650 USD th in May 2022. This records a decrease from the previous number of 91,314.369 USD th for Apr 2022. CN: Export: Other Protein Substance & their Derivative data is updated monthly, averaging 37,860.913 USD th from Jan 2009 to May 2022, with 161 observations. The data reached an all-time high of 95,982.963 USD th in Jan 2022 and a record low of 0.000 USD th in Jan 2009. CN: Export: Other Protein Substance & their Derivative data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
80,656.650 May 2022 monthly Jan 2009 - May 2022

View China's Export: Other Protein Substance & their Derivative from Jan 2009 to May 2022 in the chart:

China Export: Other Protein Substance & their Derivative

China Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Feb 2018. CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 data is updated monthly, averaging 24.190 USD th from Jan 2011 to Mar 2018, with 86 observations. The data reached an all-time high of 677.309 USD th in Aug 2017 and a record low of 0.000 USD th in Mar 2018. CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29 from Jan 2011 to Mar 2018 in the chart:

China China Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29

China Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses

2014 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses data was reported at 0.024 USD th in Mar 2018. This records a decrease from the previous number of 0.050 USD th for Feb 2018. CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses data is updated monthly, averaging 0.013 USD th from Jan 2014 to Mar 2018, with 28 observations. The data reached an all-time high of 0.080 USD th in Nov 2016 and a record low of 0.002 USD th in Jan 2015. CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.024 Mar 2018 monthly Jan 2014 - Mar 2018

View China's China Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses from Jan 2014 to Mar 2018 in the chart:

China China Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses

China Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose

2012 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data was reported at 7.011 USD th in Mar 2018. This records an increase from the previous number of 0.000 USD th for Jan 2018. CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data is updated monthly, averaging 13.205 USD th from Mar 2012 to Mar 2018, with 67 observations. The data reached an all-time high of 464.751 USD th in Jan 2015 and a record low of 0.000 USD th in Jan 2018. CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
7.011 Mar 2018 monthly Mar 2012 - Mar 2018

View China's China Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose from Mar 2012 to Mar 2018 in the chart:

China China Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose

China Export: Toxin under Sensitive Items Control

2014 - 2018 | Monthly | USD th | General Administration of Customs

CN: Export: Toxin under Sensitive Items Control data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Jan 2018. CN: Export: Toxin under Sensitive Items Control data is updated monthly, averaging 0.000 USD th from Jan 2014 to Mar 2018, with 31 observations. The data reached an all-time high of 32.785 USD th in Dec 2015 and a record low of 0.000 USD th in Mar 2018. CN: Export: Toxin under Sensitive Items Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Mar 2018 monthly Jan 2014 - Mar 2018

View China's China Export: Toxin under Sensitive Items Control from Jan 2014 to Mar 2018 in the chart:

China China Export: Toxin under Sensitive Items Control

Import: Active Yeast

2008 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Active Yeast data was reported at 705.972 USD th in May 2022. This records an increase from the previous number of 617.724 USD th for Apr 2022. CN: Import: Active Yeast data is updated monthly, averaging 637.471 USD th from Jan 2008 to May 2022, with 173 observations. The data reached an all-time high of 2,811.162 USD th in Jun 2013 and a record low of 26.505 USD th in Feb 2015. CN: Import: Active Yeast data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
705.972 May 2022 monthly Jan 2008 - May 2022

View China's Import: Active Yeast from Jan 2008 to May 2022 in the chart:

China Import: Active Yeast

China Import: Bacteria & Virus under Sensitive Item Control

2012 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Bacteria & Virus under Sensitive Item Control data was reported at 1.858 USD th in Jan 2018. This records an increase from the previous number of 1.750 USD th for Jan 2017. CN: Import: Bacteria & Virus under Sensitive Item Control data is updated monthly, averaging 0.088 USD th from Feb 2012 to Jan 2018, with 9 observations. The data reached an all-time high of 1.858 USD th in Jan 2018 and a record low of 0.000 USD th in Oct 2015. CN: Import: Bacteria & Virus under Sensitive Item Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
1.858 Jan 2018 monthly Feb 2012 - Jan 2018

View China's China Import: Bacteria & Virus under Sensitive Item Control from Feb 2012 to Jan 2018 in the chart:

China China Import: Bacteria & Virus under Sensitive Item Control

China Import: Blood Preparation of Endangered Animal

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Blood Preparation of Endangered Animal data was reported at 0.000 USD th in Mar 2018. This stayed constant from the previous number of 0.000 USD th for Feb 2018. CN: Import: Blood Preparation of Endangered Animal data is updated monthly, averaging 0.000 USD th from Jan 2011 to Mar 2018, with 86 observations. The data reached an all-time high of 1.558 USD th in Jan 2016 and a record low of 0.000 USD th in Mar 2018. CN: Import: Blood Preparation of Endangered Animal data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Import: Blood Preparation of Endangered Animal from Jan 2011 to Mar 2018 in the chart:

China China Import: Blood Preparation of Endangered Animal

Import: Casein

2008 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Casein data was reported at 19,852.420 USD th in May 2022. This records an increase from the previous number of 9,085.049 USD th for Apr 2022. CN: Import: Casein data is updated monthly, averaging 2,529.833 USD th from Jan 2008 to May 2022, with 173 observations. The data reached an all-time high of 19,852.420 USD th in May 2022 and a record low of 261.491 USD th in Feb 2009. CN: Import: Casein data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
19,852.420 May 2022 monthly Jan 2008 - May 2022

View China's Import: Casein from Jan 2008 to May 2022 in the chart:

China Import: Casein

Import: Caseinate & Other Casein Derivative, Casein Glue

2008 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Caseinate & Other Casein Derivative, Casein Glue data was reported at 16,253.888 USD th in May 2022. This records a decrease from the previous number of 20,032.956 USD th for Apr 2022. CN: Import: Caseinate & Other Casein Derivative, Casein Glue data is updated monthly, averaging 8,722.083 USD th from Jan 2008 to May 2022, with 173 observations. The data reached an all-time high of 27,612.372 USD th in Nov 2021 and a record low of 1,159.471 USD th in Jan 2009. CN: Import: Caseinate & Other Casein Derivative, Casein Glue data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
16,253.888 May 2022 monthly Jan 2008 - May 2022

View China's Import: Caseinate & Other Casein Derivative, Casein Glue from Jan 2008 to May 2022 in the chart:

China Import: Caseinate & Other Casein Derivative, Casein Glue

China Import: Compound Preparation, Containing Condeine, its Derivative & Salt

2011 - 2016 | Monthly | USD th | General Administration of Customs

CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt data was reported at 2,196.260 USD th in Dec 2016. This records an increase from the previous number of 116.470 USD th for Nov 2016. CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt data is updated monthly, averaging 2,903.618 USD th from Jan 2011 to Dec 2016, with 69 observations. The data reached an all-time high of 9,702.759 USD th in Aug 2012 and a record low of 0.000 USD th in May 2015. CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
2,196.260 Dec 2016 monthly Jan 2011 - Dec 2016

View China's China Import: Compound Preparation, Containing Condeine, its Derivative & Salt from Jan 2011 to Dec 2016 in the chart:

China China Import: Compound Preparation, Containing Condeine, its Derivative & Salt

Import: Contraceptive Preparation Based On Hormone

2009 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Contraceptive Preparation Based On Hormone data was reported at 22,218.113 USD th in May 2022. This records an increase from the previous number of 7,216.383 USD th for Apr 2022. CN: Import: Contraceptive Preparation Based On Hormone data is updated monthly, averaging 4,890.923 USD th from Jan 2009 to May 2022, with 161 observations. The data reached an all-time high of 43,754.413 USD th in Sep 2021 and a record low of 0.000 USD th in Feb 2015. CN: Import: Contraceptive Preparation Based On Hormone data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
7,216.383 Apr 2022 monthly Jan 2009 - Apr 2022

View China's Import: Contraceptive Preparation Based On Hormone from Jan 2009 to Apr 2022 in the chart:

China Import: Contraceptive Preparation Based On Hormone

China Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)

2014 - 2016 | Monthly | USD th | General Administration of Customs

CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data was reported at 464.526 USD th in Dec 2016. This records an increase from the previous number of 98.785 USD th for Nov 2016. CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data is updated monthly, averaging 182.344 USD th from Jan 2014 to Dec 2016, with 36 observations. The data reached an all-time high of 674.100 USD th in Dec 2014 and a record low of 0.000 USD th in May 2016. CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
464.526 Dec 2016 monthly Jan 2014 - Dec 2016

View China's China Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer) from Jan 2014 to Dec 2016 in the chart:

China China Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)

China Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data was reported at 0.000 USD th in Feb 2018. This stayed constant from the previous number of 0.000 USD th for Dec 2017. CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data is updated monthly, averaging 0.000 USD th from Jan 2011 to Feb 2018, with 65 observations. The data reached an all-time high of 0.030 USD th in Nov 2012 and a record low of 0.000 USD th in Feb 2018. CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.000 Feb 2018 monthly Jan 2011 - Feb 2018

View China's China Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal from Jan 2011 to Feb 2018 in the chart:

China China Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal

China Import: Insulin-Like Growth Factors-1

2014 - 2016 | Monthly | USD th | General Administration of Customs

CN: Import: Insulin-Like Growth Factors-1 data was reported at 0.533 USD th in May 2016. This records a decrease from the previous number of 0.574 USD th for Dec 2015. CN: Import: Insulin-Like Growth Factors-1 data is updated monthly, averaging 12.513 USD th from Mar 2014 to May 2016, with 12 observations. The data reached an all-time high of 132.476 USD th in Aug 2014 and a record low of 0.059 USD th in Mar 2014. CN: Import: Insulin-Like Growth Factors-1 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
0.533 May 2016 monthly Mar 2014 - May 2016

View China's China Import: Insulin-Like Growth Factors-1 from Mar 2014 to May 2016 in the chart:

China China Import: Insulin-Like Growth Factors-1

Import: Medicament Containing Artemisinin & their Derivative

2009 - 2020 | Monthly | USD th | General Administration of Customs

CN: Import: Medicament Containing Artemisinin & their Derivative data was reported at 4.808 USD th in Nov 2020. This records an increase from the previous number of 0.000 USD th for Dec 2016. CN: Import: Medicament Containing Artemisinin & their Derivative data is updated monthly, averaging 0.000 USD th from Jan 2009 to Nov 2020, with 92 observations. The data reached an all-time high of 566.425 USD th in Jun 2009 and a record low of 0.000 USD th in Dec 2016. CN: Import: Medicament Containing Artemisinin & their Derivative data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
4.808 Nov 2020 monthly Jan 2009 - Nov 2020

View China's Import: Medicament Containing Artemisinin & their Derivative from Jan 2009 to Nov 2020 in the chart:

China Import: Medicament Containing Artemisinin & their Derivative

China Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose

2011 - 2016 | Monthly | USD th | General Administration of Customs

CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data was reported at 10,507.459 USD th in Dec 2016. This records a decrease from the previous number of 23,923.061 USD th for Nov 2016. CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data is updated monthly, averaging 18,063.950 USD th from Jan 2011 to Dec 2016, with 72 observations. The data reached an all-time high of 36,984.741 USD th in Aug 2011 and a record low of 7,280.851 USD th in Jan 2016. CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
10,507.459 Dec 2016 monthly Jan 2011 - Dec 2016

View China's China Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose from Jan 2011 to Dec 2016 in the chart:

China China Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose

Import: Other Albumin & its Salt

2009 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Other Albumin & its Salt data was reported at 692.842 USD th in May 2022. This records an increase from the previous number of 508.921 USD th for Apr 2022. CN: Import: Other Albumin & its Salt data is updated monthly, averaging 244.922 USD th from Jan 2009 to May 2022, with 161 observations. The data reached an all-time high of 2,253.018 USD th in Dec 2018 and a record low of 0.000 USD th in Jan 2009. CN: Import: Other Albumin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
692.842 May 2022 monthly Jan 2009 - May 2022

View China's Import: Other Albumin & its Salt from Jan 2009 to May 2022 in the chart:

China Import: Other Albumin & its Salt

Import: Other Antisera, Other Blood Fractions & Modified Immunological Product

2012 - 2016 | Monthly | USD th | General Administration of Customs

CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product data was reported at 518,281.186 USD th in Dec 2016. This records a decrease from the previous number of 524,100.851 USD th for Nov 2016. CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product data is updated monthly, averaging 275,510.844 USD th from Jan 2012 to Dec 2016, with 60 observations. The data reached an all-time high of 611,170.844 USD th in Dec 2015 and a record low of 76,453.008 USD th in Jan 2012. CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
518,281.186 Dec 2016 monthly Jan 2012 - Dec 2016

View China's Import: Other Antisera, Other Blood Fractions & Modified Immunological Product from Jan 2012 to Dec 2016 in the chart:

China Import: Other Antisera, Other Blood Fractions & Modified Immunological Product

China Import: Other Bacteria & Virus

2009 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Other Bacteria & Virus data was reported at 27,444.124 USD th in Mar 2018. This records an increase from the previous number of 10,548.710 USD th for Feb 2018. CN: Import: Other Bacteria & Virus data is updated monthly, averaging 6,726.249 USD th from Jan 2009 to Mar 2018, with 111 observations. The data reached an all-time high of 27,444.124 USD th in Mar 2018 and a record low of 0.000 USD th in Jan 2009. CN: Import: Other Bacteria & Virus data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
27,444.124 Mar 2018 monthly Jan 2009 - Mar 2018

View China's China Import: Other Bacteria & Virus from Jan 2009 to Mar 2018 in the chart:

China China Import: Other Bacteria & Virus

China Import: Other Genetic Material & Gene-modified Organism

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Other Genetic Material & Gene-modified Organism data was reported at 2,386.022 USD th in Mar 2018. This records an increase from the previous number of 1,130.250 USD th for Feb 2018. CN: Import: Other Genetic Material & Gene-modified Organism data is updated monthly, averaging 1,056.006 USD th from Jan 2011 to Mar 2018, with 87 observations. The data reached an all-time high of 3,596.019 USD th in Dec 2017 and a record low of 28.120 USD th in Jan 2012. CN: Import: Other Genetic Material & Gene-modified Organism data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
2,386.022 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Import: Other Genetic Material & Gene-modified Organism from Jan 2011 to Mar 2018 in the chart:

China China Import: Other Genetic Material & Gene-modified Organism

Import: Other Insulin & its Salt

2011 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Other Insulin & its Salt data was reported at 93,507.113 USD th in May 2022. This records a decrease from the previous number of 168,599.939 USD th for Apr 2022. CN: Import: Other Insulin & its Salt data is updated monthly, averaging 28,604.741 USD th from Mar 2011 to May 2022, with 114 observations. The data reached an all-time high of 228,235.802 USD th in May 2021 and a record low of 0.000 USD th in Nov 2017. CN: Import: Other Insulin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
93,507.113 May 2022 monthly Mar 2011 - May 2022

View China's Import: Other Insulin & its Salt from Mar 2011 to May 2022 in the chart:

China Import: Other Insulin & its Salt

China Import: Other Single Preparation Containing Narcotic Drug of Chapter 29

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 data was reported at 2,360.661 USD th in Mar 2018. This records an increase from the previous number of 977.959 USD th for Feb 2018. CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 data is updated monthly, averaging 2,206.985 USD th from Jan 2011 to Mar 2018, with 83 observations. The data reached an all-time high of 19,672.476 USD th in Nov 2016 and a record low of 0.000 USD th in Dec 2017. CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
2,360.661 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Import: Other Single Preparation Containing Narcotic Drug of Chapter 29 from Jan 2011 to Mar 2018 in the chart:

China China Import: Other Single Preparation Containing Narcotic Drug of Chapter 29

China Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose

2012 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data was reported at 676.855 USD th in Mar 2018. This records an increase from the previous number of 148.957 USD th for Jan 2018. CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data is updated monthly, averaging 28.919 USD th from Mar 2012 to Mar 2018, with 67 observations. The data reached an all-time high of 4,434.812 USD th in Jun 2016 and a record low of 0.000 USD th in Aug 2017. CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
676.855 Mar 2018 monthly Mar 2012 - Mar 2018

View China's China Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose from Mar 2012 to Mar 2018 in the chart:

China China Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose

Import: Recombinant Human Insulin & its Salt

2011 - 2022 | Monthly | USD th | General Administration of Customs

CN: Import: Recombinant Human Insulin & its Salt data was reported at 16,483.648 USD th in May 2022. This records a decrease from the previous number of 52,588.400 USD th for Mar 2022. CN: Import: Recombinant Human Insulin & its Salt data is updated monthly, averaging 5,206.096 USD th from Jan 2011 to May 2022, with 130 observations. The data reached an all-time high of 59,961.366 USD th in Feb 2019 and a record low of 0.000 USD th in May 2015. CN: Import: Recombinant Human Insulin & its Salt data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines.

Last Frequency Range
16,483.648 May 2022 monthly Jan 2011 - May 2022

View China's Import: Recombinant Human Insulin & its Salt from Jan 2011 to May 2022 in the chart:

China Import: Recombinant Human Insulin & its Salt

China Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale)

2014 - 2016 | Monthly | USD th | General Administration of Customs

CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data was reported at 19,262.745 USD th in Dec 2016. This records an increase from the previous number of 9,734.486 USD th for Nov 2016. CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data is updated monthly, averaging 3,378.697 USD th from Mar 2014 to Dec 2016, with 16 observations. The data reached an all-time high of 19,262.745 USD th in Dec 2016 and a record low of 12.389 USD th in Aug 2016. CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
19,262.745 Dec 2016 monthly Mar 2014 - Dec 2016

View China's China Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale) from Mar 2014 to Dec 2016 in the chart:

China China Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale)

China Import: Toxin under Sensitive Items Control

2014 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Toxin under Sensitive Items Control data was reported at 28,996.239 USD th in Mar 2018. This records a decrease from the previous number of 29,031.874 USD th for Jan 2018. CN: Import: Toxin under Sensitive Items Control data is updated monthly, averaging 13,564.839 USD th from Jan 2014 to Mar 2018, with 31 observations. The data reached an all-time high of 53,409.750 USD th in Jun 2017 and a record low of 0.000 USD th in Nov 2017. CN: Import: Toxin under Sensitive Items Control data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
28,996.239 Mar 2018 monthly Jan 2014 - Mar 2018

View China's China Import: Toxin under Sensitive Items Control from Jan 2014 to Mar 2018 in the chart:

China China Import: Toxin under Sensitive Items Control

China Import: Venom Substance Prepared for Therapeutic or Prophylactic Use

2011 - 2018 | Monthly | USD th | General Administration of Customs

CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use data was reported at 66.150 USD th in Mar 2018. This stayed constant from the previous number of 66.150 USD th for Jan 2018. CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use data is updated monthly, averaging 54.285 USD th from Jan 2011 to Mar 2018, with 62 observations. The data reached an all-time high of 149.805 USD th in Feb 2012 and a record low of 9.691 USD th in Dec 2013. CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use data remains active status in CEIC and is reported by General Administration of Customs. The data is categorized under China Premium Database’s Pharmaceutical Sector – Table CN.RTB: Pharmaceutical Trade: Other Biochemicals and Western Medicines. According to the Customs: 'Since 2020, the Customs will no longer release separate trade data for January and February.' Data in February are the cumulative figures of January and February. 根据海关: '从2020年开始,全国海关不再单独发布1、2月份的进出口数据。' 2月份的数据是1月和2月的累计数。

Last Frequency Range
66.150 Mar 2018 monthly Jan 2011 - Mar 2018

View China's China Import: Venom Substance Prepared for Therapeutic or Prophylactic Use from Jan 2011 to Mar 2018 in the chart:

China China Import: Venom Substance Prepared for Therapeutic or Prophylactic Use
CN: Export: Agar
CN: Export: Bacteria & Virus under Sensitive Item Control
CN: Export: Buprenorphine Transdermal Patch (Put Up in Measured Doses & in Forms or Packing for Retail Sale)
CN: Export: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)
CN: Export: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal
CN: Export: Extract of Gland or Other Organ or of their Secretion, of Human
CN: Export: Extract of Gland or Other Organ or of their Secretion, of Others
CN: Export: Insulin-Like Growth Factors-1
CN: Export: Medicament Containing Artemisinin & their Derivative
CN: Export: Medicament Containing Artemisinin & their Derivative, Not in Measured Dose
CN: Export: Medicament Containing Quinine & its Salt, Not in Measured Dose
CN: Export: Medicament Containing Taxinol
CN: Export: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose
CN: Export: Other Antisera, Other Blood Fractions & Modified Immunological Product
CN: Export: Other Bacteria & Virus
CN: Export: Other Insulin & its Salt
CN: Export: Other Medicament, in Measured Dose
CN: Export: Other Protein Substance & their Derivative
CN: Export: Other Single Preparation Containing Psychotropic Substance of Chapter 29
CN: Export: Other Substances of Endangered Animals for Therapeutic or Prophylactic Uses
CN: Export: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose
CN: Export: Toxin under Sensitive Items Control
CN: Import: Active Yeast
CN: Import: Bacteria & Virus under Sensitive Item Control
CN: Import: Blood Preparation of Endangered Animal
CN: Import: Casein
CN: Import: Caseinate & Other Casein Derivative, Casein Glue
CN: Import: Compound Preparation, Containing Condeine, its Derivative & Salt
CN: Import: Contraceptive Preparation Based On Hormone
CN: Import: Erythropoietin (EPO) & its Analogues (including Erythropoietin-β; Peinisha Peptide; Erythropoietin; Hypoxia Inducible Factor Stahilizer)
CN: Import: Extract of Gland or Other Organ or of their Secretion, of Endangered Wild Animal
CN: Import: Insulin-Like Growth Factors-1
CN: Import: Medicament Containing Artemisinin & their Derivative
CN: Import: Medicament, Not Elsewhere Specified or Included, Not in Measured Dose
CN: Import: Other Albumin & its Salt
CN: Import: Other Antisera, Other Blood Fractions & Modified Immunological Product
CN: Import: Other Bacteria & Virus
CN: Import: Other Genetic Material & Gene-modified Organism
CN: Import: Other Insulin & its Salt
CN: Import: Other Single Preparation Containing Narcotic Drug of Chapter 29
CN: Import: Preparation Containing Nitroxinil, Flunixin Meglumine, Meloxicam for Veterinary Purpose
CN: Import: Recombinant Human Insulin & its Salt
CN: Import: Single Preparations, Containing Alkaloids Narcotic Drug & its Derivatives (Put Up in Measured Doses & in Forms or Packing for Retail Sale)
CN: Import: Toxin under Sensitive Items Control
CN: Import: Venom Substance Prepared for Therapeutic or Prophylactic Use
Unlimited access tailored to your data needs
Flexible monthly access to CEIC data